86 related articles for article (PubMed ID: 2112756)
1. Whole blood collection using metered anticoagulation for production of Factor VIII and Factor IX.
Penny A; Pinner M; Townley A; Mosley P; Smith J; Lane R; Munford C; Robinson A
Prog Clin Biol Res; 1990; 337():487-9. PubMed ID: 2112756
[No Abstract] [Full Text] [Related]
2. Use of plasma with high levels of ionised calcium in the production of model scale coagulation factor concentrates.
Farrugia A; Douglas S; James J; Whyte G; Herrington R
Thromb Haemost; 1990 Nov; 64(3):374-8. PubMed ID: 2128967
[TBL] [Abstract][Full Text] [Related]
3. Plasma fractionation in blood transfusion service.
Haskó F; Salamon M; Bartha K; Dobó P
Dev Biol Stand; 1987; 67():39-48. PubMed ID: 3111912
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C and pasteurised factor VIII and IX concentrates.
Klarmann D; Kreuz W; Auerswald G; Auberger K; Rabenau H; Gürtler L; Roggendorf M
Thromb Haemost; 1995 Apr; 73(4):736-7. PubMed ID: 7495095
[No Abstract] [Full Text] [Related]
5. The current status of blood fractionation in the United States.
Sgouris JT
Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
[No Abstract] [Full Text] [Related]
6. An extensive study of donor plasmapheresis using a membrane method by the special study group of the Japanese Red Cross Society.
Ikeda H; Tomono T; Sakai E; Endo N; Yokoyama S; Ogawa M; Shiraki H; Kameko S; Sekiguchi S
Prog Clin Biol Res; 1990; 337():503-6. PubMed ID: 2112757
[No Abstract] [Full Text] [Related]
7. Purity of concentrates for substitution therapy: acceptable and undesirable contaminants--Madrid 1978.
Scand J Haematol Suppl; 1980; 35():65-89. PubMed ID: 6770460
[No Abstract] [Full Text] [Related]
8. Recommendations of the subcommittee on human factor VIII (AHF) and factor IX (PTC) preparations.
Wagner RH
Thromb Diath Haemorrh Suppl; 1968; 35():235-7. PubMed ID: 5761065
[No Abstract] [Full Text] [Related]
9. Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex.
Schimpf K; Schwarz P; Kunschak M
Thromb Haemost; 1995 Mar; 73(3):553-5. PubMed ID: 7667845
[No Abstract] [Full Text] [Related]
10. Modern treatment of hemophilia: from the shadows towards the light.
Mannucci PM
Thromb Haemost; 1993 Jul; 70(1):17-23. PubMed ID: 8236096
[No Abstract] [Full Text] [Related]
11. Effects of plasma collection systems and processing parameters on the quality of factor IX concentrate.
Farrugia A; Spiers D; Young I; Oates A; Herrington R; Damianos F
Vox Sang; 1989; 57(1):4-9. PubMed ID: 2800464
[TBL] [Abstract][Full Text] [Related]
12. [Improvement in anti-hemophilic preparations and arts problems. 1. Heat-treated concentrates].
Ikematsu S; Yorifuji H; Arai M; Fukutake K
Rinsho Ketsueki; 1988 May; 29(5):628-34. PubMed ID: 3145993
[No Abstract] [Full Text] [Related]
13. [Donor selection for the production of factor XIII preparations].
Uteg KH; Tausendfreund K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):447-55. PubMed ID: 2414175
[TBL] [Abstract][Full Text] [Related]
14. [Isolation of blood coagulation factors (VII, VIII and IX)].
Dzegilenko NB
Gematol Transfuziol; 1990 May; 35(5):38-40. PubMed ID: 2118467
[No Abstract] [Full Text] [Related]
15. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
Sultan Y; Boyeldieu D; Stieltjes N
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717
[TBL] [Abstract][Full Text] [Related]
16. Blood products.
Med Lett Drugs Ther; 1979 Nov; 21(23):93-6. PubMed ID: 502967
[No Abstract] [Full Text] [Related]
17. Heat inactivation of human immunodeficiency virus in lyophilized factor VIII and factor IX concentrates.
Piszkiewicz D; Bourret L; Lieu M; Hattley K; Thomas W; Cabradilla CD; Kingdon H; Menache D
Thromb Res; 1987 Jul; 47(2):235-41. PubMed ID: 3116716
[No Abstract] [Full Text] [Related]
18. Is the poor recovery of commercial recombinant factors VIII and IX caused by damage from monoclonal antibody purification?
Shanbrom E
Thromb Haemost; 2002 Oct; 88(4):700. PubMed ID: 12362253
[No Abstract] [Full Text] [Related]
19. [Transmission of hepatitis C by factor concentrates].
Aguilar C; Lucía JF
Sangre (Barc); 1996 Apr; 41(2):160-1. PubMed ID: 9045360
[No Abstract] [Full Text] [Related]
20. [Possibilities to elevate the factor VIII yield].
Uteg KH; Tausendfreund K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(1):153-69. PubMed ID: 2439416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
